Actively Recruiting
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
Led by Mayo Clinic · Updated on 2025-11-24
614
Participants Needed
2
Research Sites
565 weeks
Total Duration
On this page
Sponsors
M
Mayo Clinic
Lead Sponsor
N
National Institute on Aging (NIA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.
CONDITIONS
Official Title
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women who previously participated in this study
- Currently aged 60 years and older
- More than six months post chemotherapy or major surgery requiring general anesthesia
- Willing and able to sign informed consent
- African American Women (for Mayo Clinic Jacksonville site only)
You will not qualify if you...
- Not able to read and speak English
- In hospice care
- Claustrophobic
- If undergoing Tau imaging, cannot have QT prolongation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Mayo Clinic
Jacksonville, Florida, United States, 32224
Actively Recruiting
2
Mayo Clinic
Rochester, Minnesota, United States, 55905
Enrolling by Invitation
Research Team
J
June Kendall-Thomas, CRC
CONTACT
D
Desirae Howe-Clayton, CRC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here